Galapagos NV
GLPG
#5074
Rank
NZ$3.19 B
Marketcap
NZ$47.62
Share price
0.00%
Change (1 day)
-12.14%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): NZ-$0.93

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.70. In 2025 the company made an earnings per share (EPS) of NZ$9.82 an increase over its 2024 EPS that were of NZ$2.00.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-109.43%
2025NZ$9.82390.86%
2024NZ$2.00-67.16%
2023NZ$6.09-199.64%
2022NZ-$6.1299.03%
2021NZ-$3.07-68.98%
2020NZ-$9.91-298.06%
2019NZ$5.00-554.64%
2018NZ-$1.10-77.18%
2017NZ-$4.82-326.21%
2016NZ$2.13-134.19%
2015NZ-$6.23-371.34%
2014NZ$2.30-445.98%
2013NZ-$0.6632.88%
2012NZ-$0.50-82.07%
2011NZ-$2.79-817.9%
2010NZ$0.3912.73%
2009NZ$0.34-120.79%
2008NZ-$1.66-37.67%
2007NZ-$2.6639.64%
2006NZ-$1.9028.17%
2005NZ-$1.496.25%
2004NZ-$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.00-2,244.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.20-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.53-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.40-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.14-977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.94-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.67-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$6.17-981.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.35-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel